Literature DB >> 24155553

Stem cells in regenerative medicine.

Eva Sykova1, Serhiy Forostyak.   

Abstract

BACKGROUND: A number of cardiovascular, neurological, musculoskeletal and other diseases have a limited capacity for repair and only a modest progress has been made in treatment of brain diseases. The discovery of stem cells has opened new possibilities for the treatment of these maladies, and cell therapy now stands at the cutting-edge of modern regenerative medicine and tissue engineering. Experimental data and the first clinical trials employing stem cells have shown their broad therapeutic potential and have brought hope to patients suffering from devastating pathologies of different organs and systems. AIMS: Here, we briefly review the main achievements and trends in cell-based therapy, with an emphasis on the main types of stem cells: embryonic, mesenchymal stromal and induced pluripotent cells. DISCUSSION: Many questions regarding the application of stem cells remain unanswered, particularly tumorigenicity, immune rejection and danger of gene manipulation. Currently, only MSC seems to be safe and might be considered to be a leading candidate for human application to treat pathologies that affect the cardiovascular, neurological and musculoskeletal systems.

Entities:  

Keywords:  Clinical Trials; Embryonic Stem Cells; Induced Pluripotent Stem Cells; Mesenchymal Stromal Cells; PACS: 87.19.L-; 87.19.LW; Stem Cells

Year:  2013        PMID: 24155553      PMCID: PMC3806066          DOI: 10.3136/islsm.22.87

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  56 in total

1.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.

Authors:  C P Hofstetter; E J Schwarz; D Hess; J Widenfalk; A El Manira; Darwin J Prockop; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

2.  Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.

Authors:  Letizia Mazzini; Katia Mareschi; Ivana Ferrero; Massimo Miglioretti; Alessandro Stecco; Serena Servo; Alessandro Carriero; Francesco Monaco; Franca Fagioli
Journal:  Cytotherapy       Date:  2011-09-28       Impact factor: 5.414

3.  In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.

Authors:  Nathaniel S Hwang; Shyni Varghese; H Janice Lee; Zijun Zhang; Zhaohui Ye; Jongwoo Bae; Linzhao Cheng; Jennifer Elisseeff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

4.  Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.

Authors:  Hui Gai; Elaine Lai-Han Leung; Peter D Costantino; Jerell R Aguila; David M Nguyen; Louis M Fink; David C Ward; Yupo Ma
Journal:  Cell Biol Int       Date:  2009-09-01       Impact factor: 3.612

Review 5.  Intracerebral transplantation of dopamine neurons: understanding the functional role of the mesolimbocortical dopamine system and developing a therapy for Parkinson's disease.

Authors:  P Brundin; R E Strecker; F H Gage; O Lindvall; A Björklund
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

6.  Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.

Authors:  Serhiy Forostyak; Pavla Jendelova; Miroslava Kapcalova; David Arboleda; Eva Sykova
Journal:  Cytotherapy       Date:  2011-07-08       Impact factor: 5.414

7.  Analysis of in vitro and in vivo characteristics of human embryonic stem cell-derived neural precursors.

Authors:  Nataliya Kozubenko; Karolina Turnovcova; Miroslava Kapcalova; Olena Butenko; Miroslava Anderova; Vendula Rusnakova; Mikael Kubista; Ales Hampl; Pavla Jendelova; Eva Sykova
Journal:  Cell Transplant       Date:  2009-12-18       Impact factor: 4.064

8.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Nikos Werner; Jürgen Haase; Jörg Neuzner; Alfried Germing; Bernd Mark; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2006-11-10       Impact factor: 29.983

9.  The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors.

Authors:  Christine Seminatore; Jerome Polentes; Ditte Ellman; Nataliya Kozubenko; Valerie Itier; Samir Tine; Laurent Tritschler; Marion Brenot; Emmanuelle Guidou; Johanna Blondeau; Mickael Lhuillier; Aurore Bugi; Laetitia Aubry; Pavla Jendelova; Eva Sykova; Anselme L Perrier; Bente Finsen; Brigitte Onteniente
Journal:  Stroke       Date:  2009-11-25       Impact factor: 7.914

10.  Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord.

Authors:  Weidong Gu; Fujun Zhang; Qingsheng Xue; Zhengwen Ma; Peihua Lu; Buwei Yu
Journal:  Neuropathology       Date:  2009-10-21       Impact factor: 1.906

View more
  18 in total

Review 1.  The future of stem cell therapy in hernia and abdominal wall repair.

Authors:  A H Petter-Puchner; R H Fortelny; S Gruber-Blum; H Redl; U Dietz
Journal:  Hernia       Date:  2014-08-14       Impact factor: 4.739

Review 2.  Neural is Fundamental: Neural Stemness as the Ground State of Cell Tumorigenicity and Differentiation Potential.

Authors:  Ying Cao
Journal:  Stem Cell Rev Rep       Date:  2021-10-29       Impact factor: 5.739

Review 3.  Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products.

Authors:  Shin Kawamata; Hoshimi Kanemura; Noriko Sakai; Masayo Takahashi; Masahiro J Go
Journal:  J Clin Med       Date:  2015-01-14       Impact factor: 4.241

4.  Getting it right before transplantation: example of a stem cell model with regenerative potential for the CNS.

Authors:  Cedric Viero; Oksana Forostyak; Eva Sykova; Govindan Dayanithi
Journal:  Front Cell Dev Biol       Date:  2014-08-13

5.  Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease.

Authors:  Mariana Acquarone; Thiago M de Melo; Fernanda Meireles; Jordano Brito-Moreira; Gabriel Oliveira; Sergio T Ferreira; Newton G Castro; Fernanda Tovar-Moll; Jean-Christophe Houzel; Stevens K Rehen
Journal:  Front Cell Neurosci       Date:  2015-04-08       Impact factor: 5.505

6.  Cell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Patricia Prieto; María Fernández-Velasco; María E Fernández-Santos; Pedro L Sánchez; Verónica Terrón; Paloma Martín-Sanz; Francisco Fernández-Avilés; Lisardo Boscá
Journal:  Front Physiol       Date:  2016-11-16       Impact factor: 4.566

Review 7.  Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Authors:  Eva Sykova; Dasa Cizkova; Sarka Kubinova
Journal:  Front Cell Dev Biol       Date:  2021-07-06

8.  Comparative Histological Study on the Therapeutic Effect of Green Tea and Stem Cells in Alzheimer's Disease Complicating Experimentally Induced Diabetes.

Authors:  Hend Shafik Bassiony; Maha Baligh Zickri; Hala Gabr Metwally; Hala Ahmed Elsherif; Sarah Mohammed Alghandour; Wael Sakr
Journal:  Int J Stem Cells       Date:  2015-11       Impact factor: 2.500

9.  FTIR Spectroscopic and Molecular Analysis during Differentiation of Pluripotent Stem Cells to Pancreatic Cells.

Authors:  Gustavo Jesus Vazquez-Zapien; Monica Maribel Mata-Miranda; Virginia Sanchez-Monroy; Raul Jacobo Delgado-Macuil; David Guillermo Perez-Ishiwara; Marlon Rojas-Lopez
Journal:  Stem Cells Int       Date:  2016-08-29       Impact factor: 5.443

Review 10.  Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Chin J Traumatol       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.